首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Oncology Reports

Oncology Reports杂志,由Spandidos Publications出版,于1994年创刊,Monthly,出版语言English,ISSN:1021-335X,E-ISSN:1791-2431。

投稿咨询
Oncology Reports
Oncology Reports
Oncology Reports
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
4.7
CiteScore
7.7
期刊收录
SCI、SCIE

Oncology Reports(中文译名:《肿瘤学报告》),ISSN:1021-335X,EISSN:1791-2431,是Spandidos Publications出版的国际性学术期刊,创刊于1994年,以Monthly形式稳定发行,2026年总发文量约118篇。该刊采用非OA开放访问,学科归属为医学 - 肿瘤学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.7,2025年期刊CiteScore为7.7,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Oncology Reports长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约5.5月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDJapan、USA、South Korea、Taiwan、Italy、GERMANY (FED REP GER)等为核心发文国家与地区;NANJING MEDICAL UNIVERSITYXI'AN JIAOTONG UNIVERSITY、JILIN UNIVERSITY、FUDAN UNIVERSITY、SHANDONG UNIVERSITY、SHANGHAI JIAO TONG UNIVERSITY、SUN YAT SEN UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
ONCOLOGY 肿瘤学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 97 / 333

71

学科:ONCOLOGY SCIE Q2 117 / 333

65.02

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 98 / 328

70.3

学科:ONCOLOGY SCIE Q2 108 / 328

67.23


中国学者近期发文

1
NF-κB-driven LUZP1 promotes metastasis and chemoresistance in head and neck squamous cell carcinom

Author:Lin, Chen-Yuan; Hsieh, Ching-Yun; Lan, Hsin-Chi; Lin, Ching-Chan; Chen, Tzu-Ting; Tseng, Wei-Chi; Tsou, Yung-An; Chang, Wei-Chao

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9115

2
T cell fate regulation in EBV-associated nasopharyngeal carcinoma (Review

Author:Zhang, Liuyang; Ding, Shun; Chen, Dongzhui; Cai, Benchi; Mu, Zhonglin

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9111

3
HMGB3: A pivotal orchestrator of therapy resistance and cancer stemness in human malignancies (Review

Author:Zhang, Ju; Sun, Yifan; Wang, Lanyu; Gu, Jiayu; Hua, Ye; Shao, Jianfeng; Feng, Ninghan

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9109

4
Role of CHD4 in tumor progression, DNA damage response and treatment resistance (Review

Author:Li, Shuo; Ma, Quan; Lian, Keying; Jiang, Zhisheng; Ma, Yun

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9112

5
Mechanistic study of MUC3A in promoting progression of clear cell renal cell carcinoma via the JAK-STAT pathwa

Author:Yun, Yongyang; Ji, Xing; Hu, Shuai; Wu, Tianyu; Liu, Yixiao; Li, Zheng; Sun, Zhoujie; Zhou, Peimin; Yang, Lei; Yu, Wei

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9119

6
PINK1-mediated mitophagy enhances breast cancer proliferation through metabolic reprogrammin

Author:Guo, Zong Jin; Yu, Qian; Sha, Rui; Li, Wei; Dai, Hui Juan

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 6, pp. -. DOI: 10.3892/or.2026.9117

7
Unveiling the role of ANGPT2 in esophageal cancer: A prognostic factor and potential oncogen

Author:Zhai, Zhigang; Xue, Zhenyu; Fang, Yuan; Fan, Yixu; Li, Shijiao; Yu, Yunpeng; Chen, Chuansheng; Zhang, Kaijun; Chen, Deyu; Tang, Xiang; Ling, Rui

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 5, pp. -. DOI: 10.3892/or.2026.9098

8
Silencing of SIVA-1 promotes cisplatin resistance in gastric cancer via the Bcl-2/BAX-mediated mitochondria-dependent apoptosis pathwa

Author:Shi, Zheng-Yi; Ding, Zheng-Rong; Huang, Yu-Liang; Lei, Yuan-Rui; Huang, Hai-Bin; Qing, Yan; Deng, Miao-Ren; Lu, Xu-Man; Dong, Xu-Dong; Xia, Long-Jie; Xu, Sheng; Zhong, Xiao-Gang; Li, Lei; Kong, Fan-Biao; Wang, Xiao-Tong

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 5, pp. -. DOI: 10.3892/or.2026.9100

9
MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cell

Author:Luo, Rui; Chen, Jingping; Chen, Zhaojie; Wang, Surong; Liu, Tianfeng; Xu, Yang

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 5, pp. -. DOI: 10.3892/or.2026.9106

10
Mechanistic insights into the roles of astragalosides and Astragalus polysaccharides in gynecological and breast cancers (Review

Author:Liu, Ruixin; Lin, Zhanyu; Li, Yuelin; Ci, Yuetong; Guo, Zhengqi; Xu, Zhenguo

Journal: ONCOLOGY REPORTS. 2026; Vol. 55, Issue 5, pp. -. DOI: 10.3892/or.2026.9102


在线咨询

Oncology Reports

国际简称:ONCOL REP参考译名:肿瘤学报告

年发文量:118 CiteScore:7.7 是否预警:否 Gold OA文章占比:84.52% 研究类文章占比:58.47%

杂志社联系方式:SPANDIDOS PUBL LTD, POB 18179, ATHENS, GREECE, 116 10

Oncology Reports